Edition:
United States

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

144.53USD
18 Sep 2017
Change (% chg)

-- (--)
Prev Close
$144.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
341,076
52-wk High
$148.83
52-wk Low
$106.48

Latest Key Developments (Source: Significant Developments)

Stryker provides update regarding Sage warning letter
Wednesday, 23 Aug 2017 08:00am EDT 

Aug 23 (Reuters) - Stryker Corp ::Reg-Stryker provides an update regarding sage warning letter and revised financial guidance.Stryker Corp says informed U.S. FDA of voluntary product recall involving specific lots of oral care products sold through sage products business unit​.Stryker - ‍recalled products contain oral care solutions manufactured for sage by third-party supplier,were distributed between July 2015 and Aug 2017​.Recall is being initiated due to a potential for cross-contamination of oral care solutions.Says ‍to date, stryker has not been made aware of any serious adverse events associated with oral care products recall​.Stryker - ‍has discontinued business with third-party supplier and all oral care solutions are being manufactured in-house by Sage​.Stryker says anticipates that adjusted net earnings per diluted share will be at lower end of its previously stated range of $1.50-$1.55 for q3​.Stryker - ‍expects to resume shipping oral care products in September and anticipates a return to full supply capacity by year end​.Says ‍there have been some reports of minor irritation and allergic reaction related to the products​.Stryker - FDA warning letter sets forth concerns regarding microbiological testing methods used for all products containing solutions sold by sage.Says ‍anticipates it will resume shipping products manufactured by sage and tested under compendial method in September​.  Full Article

Novadaq receives court approval for arrangement with Stryker
Wednesday, 9 Aug 2017 05:06pm EDT 

Aug 9 (Reuters) - Novadaq Technologies Inc :Novadaq receives court approval for arrangement with Stryker.‍Ontario superior court of justice has issued a final order approving Co's deal with Stryker corporation.‍It is expected that deal with Stryker will close in Q3 of 2017​.  Full Article

Novadaq Technologies ‍shareholders approve Stryker Corp deal
Friday, 4 Aug 2017 03:05pm EDT 

Aug 4 (Reuters) - Novadaq Technologies Inc ::Shareholders approved plan of arrangement pursuant to which Stryker Corporation will acquire all outstanding shares of co.About 98.68% of shares represented at meeting in person or by proxy, voted in favour of special resolution approving arrangement​.  Full Article

Stryker Q2 adjusted earnings per share $1.53
Thursday, 27 Jul 2017 04:01pm EDT 

July 27 (Reuters) - Stryker Corp ::Reg-Stryker reports second quarter 2017 results.Sees q3 adjusted earnings per share $1.50 to $1.55.Q2 adjusted earnings per share $1.53.Q2 earnings per share $1.03.Q2 sales $3.0 billion versus I/B/E/S view $2.98 billion.Q2 earnings per share view $1.51 -- Thomson Reuters I/B/E/S.Stryker Corp qtrly orthopaedics net sales of $1.1 billion increased 5.5 pct in quarter as reported.Stryker- ‍now expect 2017 organic net sales growth to be in range of 6.5 pct to 7.0 pct.Stryker corp says now expect 2017 organic net sales growth to be in range of 6.5 pct to 7.0 pct.Stryker corp- ‍now expect 2017 adjusted net earnings per diluted share to be in range of $6.45 to $6.55​.Stryker - if foreign currency exchange rates hold near current levels, expect net sales in q3 and full year to be negatively impacted by about 0.5 pct.Fy2017 earnings per share view $6.43, revenue view $12.23 billion -- Thomson Reuters I/B/E/S.Stryker - if foreign currency exchange rates hold near current levels, expect adjusted earnings per share to be negatively impacted by approximately $0.02 in q3.Stryker - if foreign currency exchange rates hold near current levels, expect adjusted earnings per share to be negatively impacted by approximately $0.10 in full year.  Full Article

Stryker to acquire NOVADAQ Technologies
Monday, 19 Jun 2017 08:00am EDT 

June 19 (Reuters) - Stryker Corp :Reg-Stryker announces definitive agreement to acquire novadaq technologies inc..Stryker corp - deal for us$11.75 per share.Stryker corp - transaction expected to be dilutive to stryker's 2017 adjusted net earnings per diluted share by $0.03 - $0.05.Stryker corp - for 2018, transaction is expected to be neutral to stryker's earnings and accretive thereafter.Stryker corp - no change to stryker's 2017 estimated adjusted net earnings per diluted share, which is in range of $6.35 - $6.45.Fy2017 earnings per share view $6.43 -- Thomson Reuters I/B/E/S.  Full Article

Stryker Orthopaedics 2016 settlement program reaches milestone
Monday, 8 May 2017 11:45am EDT 

May 8 (Reuters) - Stryker Corp :Reg-Stryker orthopaedics 2016 settlement program reaches milestone.Stryker corp -howmedica osteonics informed courts that 95% of additional registered eligible patients have enrolled in settlement program.Stryker corp -howmedia osteonics will move forward with 2016 settlement program that provides for compensation to additional eligible u.s. Patients.Stryker corp - expected that a majority of payments under settlement agreement will be made by end of 2017.Stryker corp - compensation for u.s. Patients replaced rejuvenate modular-neck hip stem and/or abg ii modular-neck hip stem, prior to dec 19, 2016.  Full Article

Stryker declares a $0.425 per share quarterly dividend
Wednesday, 3 May 2017 08:00am EDT 

May 3 (Reuters) - Stryker Corp : :Stryker declares a $0.425 per share quarterly dividend.  Full Article

Stryker reports Q1 earnings per share $1.17
Tuesday, 25 Apr 2017 04:00pm EDT 

April 25 (Reuters) - Stryker Corp : :Stryker reports first quarter 2017 results.Sees Q2 adjusted earnings per share $1.48 to $1.52.Q1 adjusted earnings per share $1.48.Q1 earnings per share $1.17.Q1 sales $2.96 billion versus I/B/E/S view $2.9 billion.Q1 earnings per share view $1.42 -- Thomson Reuters I/B/E/S.Stryker Corp says continue to expect 2017 organic sales growth to be in range of 5.5pct - 6.5 pct.Stryker Corp - orthopaedics net sales of $1.14 billion increased 7.4 pct in quarter as reported.Sees 2017 adjusted net earnings per diluted share to be in range of $6.35 - $6.45.Q2 earnings per share view $1.52 -- Thomson Reuters I/B/E/S.Stryker Corp - if foreign currency exchange rates hold near current levels, expect net sales in Q2 & full year to be negatively impacted by about 1.0pct.Stryker- if foreign currency exchange rates hold near current levels adjusted net earnings per diluted share to be negatively impacted by about $0.03 to $0.04 in Q2.Stryker - if foreign currency exchange rates hold near current levels, expect adjusted net EPS to be hurt by about $0.10 to $0.12 in full year.FY2017 earnings per share view $6.41 -- Thomson Reuters I/B/E/S.Q2 earnings per share view $1.52, revenue view $2.97 billion -- Thomson Reuters I/B/E/S.  Full Article

Stryker Corp says CEO Kevin Lobo's total compensation for 2016 was $12.8 mln
Monday, 20 Mar 2017 01:30pm EDT 

Stryker Corp : CEO Kevin Lobo's total compensation for 2016 was $12.8 million versus $10.5 million in 2015 - SEC Filing . CFO Glenn S. Boehnlein's 2016 total compensation was $2.99 million - SEC filing . Group President, Medsurg and Neurotechnology Timothy Scannell's FY 2016 total compensation $4.8 million versus $4.4 million in FY 2015 .Group President, Orthopaedics, David Floyd's FY 2016 total compensation $4.05 million versus $3.4 million in FY 2015.  Full Article

Stryker Corp director Louise Francesconi reports sale of 3,716 shares of co's common stock
Tuesday, 31 Jan 2017 12:45pm EST 

:Stryker Corp director Louise Francesconi reports sale of 3,716 shares of co's common stock on Jan 30 - SEC filing.  Full Article

BRIEF-Stryker provides update regarding Sage warning letter

* Reg-Stryker provides an update regarding sage warning letter and revised financial guidance